nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—Indapamide—CA2—esophageal cancer	0.00493	0.144	CrCbGaD
Oxcarbazepine—Nepafenac—PTGS1—esophageal cancer	0.00328	0.096	CrCbGaD
Oxcarbazepine—Magnesium salicylate—PTGS1—esophageal cancer	0.0032	0.0938	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS1—esophageal cancer	0.00307	0.0899	CrCbGaD
Oxcarbazepine—Salsalate—PTGS1—esophageal cancer	0.00272	0.0798	CrCbGaD
Oxcarbazepine—Diplopia—Capecitabine—esophageal cancer	0.00221	0.0032	CcSEcCtD
Oxcarbazepine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.0022	0.00318	CcSEcCtD
Oxcarbazepine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00219	0.00317	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00219	0.00317	CcSEcCtD
Oxcarbazepine—Migraine—Capecitabine—esophageal cancer	0.00218	0.00315	CcSEcCtD
Oxcarbazepine—Vaginal infection—Methotrexate—esophageal cancer	0.00214	0.0031	CcSEcCtD
Oxcarbazepine—Aplastic anaemia—Methotrexate—esophageal cancer	0.00213	0.00309	CcSEcCtD
Oxcarbazepine—Bradycardia—Cisplatin—esophageal cancer	0.00212	0.00306	CcSEcCtD
Oxcarbazepine—Irritability—Capecitabine—esophageal cancer	0.00211	0.00306	CcSEcCtD
Oxcarbazepine—Mood swings—Capecitabine—esophageal cancer	0.0021	0.00304	CcSEcCtD
Oxcarbazepine—Ataxia—Capecitabine—esophageal cancer	0.00208	0.00301	CcSEcCtD
Oxcarbazepine—Mouth ulceration—Methotrexate—esophageal cancer	0.00205	0.00297	CcSEcCtD
Oxcarbazepine—Urine output increased—Methotrexate—esophageal cancer	0.00205	0.00297	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00204	0.00296	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Capecitabine—esophageal cancer	0.00202	0.00293	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00202	0.00293	CcSEcCtD
Oxcarbazepine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00202	0.00292	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Capecitabine—esophageal cancer	0.00202	0.00292	CcSEcCtD
Oxcarbazepine—Visual impairment—Cisplatin—esophageal cancer	0.002	0.0029	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00199	0.00289	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00198	0.00287	CcSEcCtD
Oxcarbazepine—Gastritis—Capecitabine—esophageal cancer	0.00196	0.00284	CcSEcCtD
Oxcarbazepine—Muscular weakness—Capecitabine—esophageal cancer	0.00195	0.00283	CcSEcCtD
Oxcarbazepine—Eye disorder—Cisplatin—esophageal cancer	0.00194	0.00281	CcSEcCtD
Oxcarbazepine—Tinnitus—Cisplatin—esophageal cancer	0.00194	0.0028	CcSEcCtD
Oxcarbazepine—Lymphadenopathy—Methotrexate—esophageal cancer	0.00193	0.0028	CcSEcCtD
Oxcarbazepine—Flushing—Cisplatin—esophageal cancer	0.00193	0.00279	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Cisplatin—esophageal cancer	0.00193	0.00279	CcSEcCtD
Oxcarbazepine—Asthma—Capecitabine—esophageal cancer	0.00191	0.00277	CcSEcCtD
Oxcarbazepine—Dysphagia—Capecitabine—esophageal cancer	0.00191	0.00277	CcSEcCtD
Oxcarbazepine—Bronchospasm—Capecitabine—esophageal cancer	0.00188	0.00272	CcSEcCtD
Oxcarbazepine—Polyuria—Methotrexate—esophageal cancer	0.00188	0.00272	CcSEcCtD
Oxcarbazepine—Immune system disorder—Cisplatin—esophageal cancer	0.00188	0.00272	CcSEcCtD
Oxcarbazepine—Nepafenac—PTGS2—esophageal cancer	0.00187	0.0549	CrCbGaD
Oxcarbazepine—Sweating increased—Capecitabine—esophageal cancer	0.00186	0.0027	CcSEcCtD
Oxcarbazepine—Arrhythmia—Cisplatin—esophageal cancer	0.00186	0.00269	CcSEcCtD
Oxcarbazepine—Bronchitis—Capecitabine—esophageal cancer	0.00184	0.00266	CcSEcCtD
Oxcarbazepine—Alopecia—Cisplatin—esophageal cancer	0.00184	0.00266	CcSEcCtD
Oxcarbazepine—Magnesium salicylate—PTGS2—esophageal cancer	0.00183	0.0536	CrCbGaD
Oxcarbazepine—Pancytopenia—Capecitabine—esophageal cancer	0.00182	0.00263	CcSEcCtD
Oxcarbazepine—Malnutrition—Cisplatin—esophageal cancer	0.00181	0.00262	CcSEcCtD
Oxcarbazepine—Neutropenia—Capecitabine—esophageal cancer	0.00179	0.00259	CcSEcCtD
Oxcarbazepine—Dysuria—Capecitabine—esophageal cancer	0.00179	0.00259	CcSEcCtD
Oxcarbazepine—Flatulence—Cisplatin—esophageal cancer	0.00178	0.00258	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00178	0.00257	CcSEcCtD
Oxcarbazepine—Piroxicam—PTGS2—esophageal cancer	0.00176	0.0514	CrCbGaD
Oxcarbazepine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00175	0.00253	CcSEcCtD
Oxcarbazepine—Weight increased—Capecitabine—esophageal cancer	0.00174	0.00252	CcSEcCtD
Oxcarbazepine—Visual disturbance—Methotrexate—esophageal cancer	0.00174	0.00252	CcSEcCtD
Oxcarbazepine—Weight decreased—Capecitabine—esophageal cancer	0.00173	0.00251	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00173	0.0025	CcSEcCtD
Oxcarbazepine—Pneumonia—Capecitabine—esophageal cancer	0.00172	0.00248	CcSEcCtD
Oxcarbazepine—Infestation—Capecitabine—esophageal cancer	0.00171	0.00247	CcSEcCtD
Oxcarbazepine—Infestation NOS—Capecitabine—esophageal cancer	0.00171	0.00247	CcSEcCtD
Oxcarbazepine—Vision blurred—Cisplatin—esophageal cancer	0.00171	0.00247	CcSEcCtD
Oxcarbazepine—Carbamazepine—ABCC2—esophageal cancer	0.0017	0.0498	CrCbGaD
Oxcarbazepine—Tremor—Cisplatin—esophageal cancer	0.0017	0.00245	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00169	0.00245	CcSEcCtD
Oxcarbazepine—Lethargy—Methotrexate—esophageal cancer	0.00168	0.00243	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00168	0.00243	CcSEcCtD
Oxcarbazepine—Renal failure—Capecitabine—esophageal cancer	0.00168	0.00243	CcSEcCtD
Oxcarbazepine—Stomatitis—Capecitabine—esophageal cancer	0.00166	0.00241	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Capecitabine—esophageal cancer	0.00166	0.0024	CcSEcCtD
Oxcarbazepine—Malaise—Cisplatin—esophageal cancer	0.00163	0.00236	CcSEcCtD
Oxcarbazepine—Haematuria—Capecitabine—esophageal cancer	0.00163	0.00235	CcSEcCtD
Oxcarbazepine—Leukopenia—Cisplatin—esophageal cancer	0.00162	0.00234	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00161	0.00234	CcSEcCtD
Oxcarbazepine—Epistaxis—Capecitabine—esophageal cancer	0.00161	0.00233	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Capecitabine—esophageal cancer	0.00159	0.0023	CcSEcCtD
Oxcarbazepine—Irritability—Methotrexate—esophageal cancer	0.00157	0.00228	CcSEcCtD
Oxcarbazepine—Convulsion—Cisplatin—esophageal cancer	0.00157	0.00227	CcSEcCtD
Oxcarbazepine—Mood swings—Methotrexate—esophageal cancer	0.00156	0.00226	CcSEcCtD
Oxcarbazepine—Bradycardia—Capecitabine—esophageal cancer	0.00156	0.00226	CcSEcCtD
Oxcarbazepine—Salsalate—PTGS2—esophageal cancer	0.00156	0.0456	CrCbGaD
Oxcarbazepine—Ataxia—Methotrexate—esophageal cancer	0.00155	0.00224	CcSEcCtD
Oxcarbazepine—Myalgia—Cisplatin—esophageal cancer	0.00154	0.00223	CcSEcCtD
Oxcarbazepine—Rhinitis—Capecitabine—esophageal cancer	0.00154	0.00222	CcSEcCtD
Oxcarbazepine—Anxiety—Cisplatin—esophageal cancer	0.00154	0.00222	CcSEcCtD
Oxcarbazepine—Hepatitis—Capecitabine—esophageal cancer	0.00153	0.00222	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00153	0.00221	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00152	0.00221	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00152	0.0022	CcSEcCtD
Oxcarbazepine—Discomfort—Cisplatin—esophageal cancer	0.00152	0.0022	CcSEcCtD
Oxcarbazepine—Pharyngitis—Capecitabine—esophageal cancer	0.00152	0.0022	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Capecitabine—esophageal cancer	0.00151	0.00218	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00148	0.00215	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00148	0.00214	CcSEcCtD
Oxcarbazepine—Visual impairment—Capecitabine—esophageal cancer	0.00148	0.00214	CcSEcCtD
Oxcarbazepine—Infection—Cisplatin—esophageal cancer	0.00147	0.00212	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Capecitabine—esophageal cancer	0.00145	0.0021	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Cisplatin—esophageal cancer	0.00145	0.0021	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00145	0.00209	CcSEcCtD
Oxcarbazepine—Tachycardia—Cisplatin—esophageal cancer	0.00144	0.00209	CcSEcCtD
Oxcarbazepine—Skin disorder—Cisplatin—esophageal cancer	0.00143	0.00208	CcSEcCtD
Oxcarbazepine—Eye disorder—Capecitabine—esophageal cancer	0.00143	0.00207	CcSEcCtD
Oxcarbazepine—Tinnitus—Capecitabine—esophageal cancer	0.00143	0.00207	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00143	0.00207	CcSEcCtD
Oxcarbazepine—Asthma—Methotrexate—esophageal cancer	0.00143	0.00206	CcSEcCtD
Oxcarbazepine—Flushing—Capecitabine—esophageal cancer	0.00142	0.00206	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Capecitabine—esophageal cancer	0.00142	0.00206	CcSEcCtD
Oxcarbazepine—Eosinophilia—Methotrexate—esophageal cancer	0.00141	0.00204	CcSEcCtD
Oxcarbazepine—Anorexia—Cisplatin—esophageal cancer	0.00141	0.00204	CcSEcCtD
Oxcarbazepine—Pancreatitis—Methotrexate—esophageal cancer	0.0014	0.00202	CcSEcCtD
Oxcarbazepine—Angiopathy—Capecitabine—esophageal cancer	0.00139	0.00201	CcSEcCtD
Oxcarbazepine—Immune system disorder—Capecitabine—esophageal cancer	0.00138	0.002	CcSEcCtD
Oxcarbazepine—Hypotension—Cisplatin—esophageal cancer	0.00138	0.002	CcSEcCtD
Oxcarbazepine—Chills—Capecitabine—esophageal cancer	0.00137	0.00199	CcSEcCtD
Oxcarbazepine—Arrhythmia—Capecitabine—esophageal cancer	0.00137	0.00198	CcSEcCtD
Oxcarbazepine—Alopecia—Capecitabine—esophageal cancer	0.00135	0.00196	CcSEcCtD
Oxcarbazepine—Pancytopenia—Methotrexate—esophageal cancer	0.00135	0.00196	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00135	0.00195	CcSEcCtD
Oxcarbazepine—Mental disorder—Capecitabine—esophageal cancer	0.00134	0.00194	CcSEcCtD
Oxcarbazepine—Malnutrition—Capecitabine—esophageal cancer	0.00133	0.00193	CcSEcCtD
Oxcarbazepine—Neutropenia—Methotrexate—esophageal cancer	0.00133	0.00193	CcSEcCtD
Oxcarbazepine—Dysuria—Methotrexate—esophageal cancer	0.00133	0.00193	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00132	0.00192	CcSEcCtD
Oxcarbazepine—Dyspnoea—Cisplatin—esophageal cancer	0.00132	0.0019	CcSEcCtD
Oxcarbazepine—Flatulence—Capecitabine—esophageal cancer	0.00131	0.0019	CcSEcCtD
Oxcarbazepine—Dysgeusia—Capecitabine—esophageal cancer	0.00131	0.00189	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.0013	0.00188	CcSEcCtD
Oxcarbazepine—Back pain—Capecitabine—esophageal cancer	0.00129	0.00187	CcSEcCtD
Oxcarbazepine—Decreased appetite—Cisplatin—esophageal cancer	0.00128	0.00186	CcSEcCtD
Oxcarbazepine—Pneumonia—Methotrexate—esophageal cancer	0.00128	0.00185	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00127	0.00184	CcSEcCtD
Oxcarbazepine—Infestation—Methotrexate—esophageal cancer	0.00127	0.00184	CcSEcCtD
Oxcarbazepine—Infestation NOS—Methotrexate—esophageal cancer	0.00127	0.00184	CcSEcCtD
Oxcarbazepine—Pain—Cisplatin—esophageal cancer	0.00126	0.00183	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00126	0.00182	CcSEcCtD
Oxcarbazepine—Vision blurred—Capecitabine—esophageal cancer	0.00126	0.00182	CcSEcCtD
Oxcarbazepine—Tremor—Capecitabine—esophageal cancer	0.00125	0.00181	CcSEcCtD
Oxcarbazepine—Renal failure—Methotrexate—esophageal cancer	0.00125	0.00181	CcSEcCtD
Oxcarbazepine—Stomatitis—Methotrexate—esophageal cancer	0.00124	0.00179	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00124	0.00179	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Cisplatin—esophageal cancer	0.00122	0.00176	CcSEcCtD
Oxcarbazepine—Haematuria—Methotrexate—esophageal cancer	0.00121	0.00175	CcSEcCtD
Oxcarbazepine—Malaise—Capecitabine—esophageal cancer	0.0012	0.00174	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.0012	0.00174	CcSEcCtD
Oxcarbazepine—Epistaxis—Methotrexate—esophageal cancer	0.0012	0.00173	CcSEcCtD
Oxcarbazepine—Vertigo—Capecitabine—esophageal cancer	0.0012	0.00173	CcSEcCtD
Oxcarbazepine—Syncope—Capecitabine—esophageal cancer	0.0012	0.00173	CcSEcCtD
Oxcarbazepine—Leukopenia—Capecitabine—esophageal cancer	0.00119	0.00173	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Methotrexate—esophageal cancer	0.00119	0.00172	CcSEcCtD
Oxcarbazepine—Palpitations—Capecitabine—esophageal cancer	0.00118	0.00171	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Capecitabine—esophageal cancer	0.00117	0.0017	CcSEcCtD
Oxcarbazepine—Body temperature increased—Cisplatin—esophageal cancer	0.00117	0.00169	CcSEcCtD
Oxcarbazepine—Cough—Capecitabine—esophageal cancer	0.00116	0.00168	CcSEcCtD
Oxcarbazepine—Hypertension—Capecitabine—esophageal cancer	0.00115	0.00167	CcSEcCtD
Oxcarbazepine—Hepatitis—Methotrexate—esophageal cancer	0.00114	0.00165	CcSEcCtD
Oxcarbazepine—Desipramine—CYP2A6—esophageal cancer	0.00114	0.0334	CrCbGaD
Oxcarbazepine—Chest pain—Capecitabine—esophageal cancer	0.00114	0.00164	CcSEcCtD
Oxcarbazepine—Arthralgia—Capecitabine—esophageal cancer	0.00114	0.00164	CcSEcCtD
Oxcarbazepine—Myalgia—Capecitabine—esophageal cancer	0.00114	0.00164	CcSEcCtD
Oxcarbazepine—Pharyngitis—Methotrexate—esophageal cancer	0.00113	0.00164	CcSEcCtD
Oxcarbazepine—Anxiety—Capecitabine—esophageal cancer	0.00113	0.00164	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00113	0.00163	CcSEcCtD
Oxcarbazepine—Discomfort—Capecitabine—esophageal cancer	0.00112	0.00162	CcSEcCtD
Oxcarbazepine—Dry mouth—Capecitabine—esophageal cancer	0.00111	0.00161	CcSEcCtD
Oxcarbazepine—Visual impairment—Methotrexate—esophageal cancer	0.0011	0.00159	CcSEcCtD
Oxcarbazepine—Confusional state—Capecitabine—esophageal cancer	0.0011	0.00159	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Cisplatin—esophageal cancer	0.00109	0.00157	CcSEcCtD
Oxcarbazepine—Infection—Capecitabine—esophageal cancer	0.00108	0.00156	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Methotrexate—esophageal cancer	0.00108	0.00156	CcSEcCtD
Oxcarbazepine—Shock—Capecitabine—esophageal cancer	0.00107	0.00155	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Capecitabine—esophageal cancer	0.00107	0.00154	CcSEcCtD
Oxcarbazepine—Eye disorder—Methotrexate—esophageal cancer	0.00107	0.00154	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00107	0.00154	CcSEcCtD
Oxcarbazepine—Tinnitus—Methotrexate—esophageal cancer	0.00106	0.00154	CcSEcCtD
Oxcarbazepine—Tachycardia—Capecitabine—esophageal cancer	0.00106	0.00154	CcSEcCtD
Oxcarbazepine—Nortriptyline—PTGS1—esophageal cancer	0.00106	0.031	CrCbGaD
Oxcarbazepine—Asthenia—Cisplatin—esophageal cancer	0.00106	0.00153	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Methotrexate—esophageal cancer	0.00106	0.00153	CcSEcCtD
Oxcarbazepine—Skin disorder—Capecitabine—esophageal cancer	0.00106	0.00153	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00105	0.00152	CcSEcCtD
Oxcarbazepine—Anorexia—Capecitabine—esophageal cancer	0.00104	0.0015	CcSEcCtD
Oxcarbazepine—Angiopathy—Methotrexate—esophageal cancer	0.00103	0.0015	CcSEcCtD
Oxcarbazepine—Immune system disorder—Methotrexate—esophageal cancer	0.00103	0.00149	CcSEcCtD
Oxcarbazepine—Chills—Methotrexate—esophageal cancer	0.00102	0.00148	CcSEcCtD
Oxcarbazepine—Hypotension—Capecitabine—esophageal cancer	0.00102	0.00147	CcSEcCtD
Oxcarbazepine—Diarrhoea—Cisplatin—esophageal cancer	0.00101	0.00146	CcSEcCtD
Oxcarbazepine—Alopecia—Methotrexate—esophageal cancer	0.00101	0.00146	CcSEcCtD
Oxcarbazepine—Mental disorder—Methotrexate—esophageal cancer	0.000999	0.00145	CcSEcCtD
Oxcarbazepine—Epinastine—ABCB1—esophageal cancer	0.000996	0.0292	CrCbGaD
Oxcarbazepine—Malnutrition—Methotrexate—esophageal cancer	0.000993	0.00144	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000992	0.00143	CcSEcCtD
Oxcarbazepine—Insomnia—Capecitabine—esophageal cancer	0.000985	0.00142	CcSEcCtD
Oxcarbazepine—Dysgeusia—Methotrexate—esophageal cancer	0.000972	0.00141	CcSEcCtD
Oxcarbazepine—Dyspnoea—Capecitabine—esophageal cancer	0.00097	0.0014	CcSEcCtD
Oxcarbazepine—Back pain—Methotrexate—esophageal cancer	0.00096	0.00139	CcSEcCtD
Oxcarbazepine—Dyspepsia—Capecitabine—esophageal cancer	0.000958	0.00139	CcSEcCtD
Oxcarbazepine—Decreased appetite—Capecitabine—esophageal cancer	0.000946	0.00137	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00094	0.00136	CcSEcCtD
Oxcarbazepine—Vomiting—Cisplatin—esophageal cancer	0.000939	0.00136	CcSEcCtD
Oxcarbazepine—Fatigue—Capecitabine—esophageal cancer	0.000939	0.00136	CcSEcCtD
Oxcarbazepine—Vision blurred—Methotrexate—esophageal cancer	0.000936	0.00135	CcSEcCtD
Oxcarbazepine—Rash—Cisplatin—esophageal cancer	0.000931	0.00135	CcSEcCtD
Oxcarbazepine—Constipation—Capecitabine—esophageal cancer	0.000931	0.00135	CcSEcCtD
Oxcarbazepine—Pain—Capecitabine—esophageal cancer	0.000931	0.00135	CcSEcCtD
Oxcarbazepine—Dermatitis—Cisplatin—esophageal cancer	0.00093	0.00135	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000921	0.00133	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Capecitabine—esophageal cancer	0.000897	0.0013	CcSEcCtD
Oxcarbazepine—Malaise—Methotrexate—esophageal cancer	0.000895	0.0013	CcSEcCtD
Oxcarbazepine—Vertigo—Methotrexate—esophageal cancer	0.000892	0.00129	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00089	0.00129	CcSEcCtD
Oxcarbazepine—Leukopenia—Methotrexate—esophageal cancer	0.000889	0.00129	CcSEcCtD
Oxcarbazepine—Nausea—Cisplatin—esophageal cancer	0.000877	0.00127	CcSEcCtD
Oxcarbazepine—Cough—Methotrexate—esophageal cancer	0.000866	0.00125	CcSEcCtD
Oxcarbazepine—Urticaria—Capecitabine—esophageal cancer	0.000865	0.00125	CcSEcCtD
Oxcarbazepine—Abdominal pain—Capecitabine—esophageal cancer	0.000861	0.00124	CcSEcCtD
Oxcarbazepine—Body temperature increased—Capecitabine—esophageal cancer	0.000861	0.00124	CcSEcCtD
Oxcarbazepine—Convulsion—Methotrexate—esophageal cancer	0.00086	0.00124	CcSEcCtD
Oxcarbazepine—Arthralgia—Methotrexate—esophageal cancer	0.000845	0.00122	CcSEcCtD
Oxcarbazepine—Chest pain—Methotrexate—esophageal cancer	0.000845	0.00122	CcSEcCtD
Oxcarbazepine—Myalgia—Methotrexate—esophageal cancer	0.000845	0.00122	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00084	0.00121	CcSEcCtD
Oxcarbazepine—Discomfort—Methotrexate—esophageal cancer	0.000835	0.00121	CcSEcCtD
Oxcarbazepine—Confusional state—Methotrexate—esophageal cancer	0.000817	0.00118	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00081	0.00117	CcSEcCtD
Oxcarbazepine—Infection—Methotrexate—esophageal cancer	0.000805	0.00116	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Capecitabine—esophageal cancer	0.000802	0.00116	CcSEcCtD
Oxcarbazepine—Diazepam—PTGS1—esophageal cancer	0.000801	0.0235	CrCbGaD
Oxcarbazepine—Nervous system disorder—Methotrexate—esophageal cancer	0.000795	0.00115	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000793	0.00115	CcSEcCtD
Oxcarbazepine—Skin disorder—Methotrexate—esophageal cancer	0.000787	0.00114	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000783	0.00113	CcSEcCtD
Oxcarbazepine—Asthenia—Capecitabine—esophageal cancer	0.000781	0.00113	CcSEcCtD
Oxcarbazepine—Anorexia—Methotrexate—esophageal cancer	0.000772	0.00112	CcSEcCtD
Oxcarbazepine—Pruritus—Capecitabine—esophageal cancer	0.00077	0.00111	CcSEcCtD
Oxcarbazepine—Hypotension—Methotrexate—esophageal cancer	0.000757	0.0011	CcSEcCtD
Oxcarbazepine—Diarrhoea—Capecitabine—esophageal cancer	0.000745	0.00108	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000738	0.00107	CcSEcCtD
Oxcarbazepine—Insomnia—Methotrexate—esophageal cancer	0.000733	0.00106	CcSEcCtD
Oxcarbazepine—Dyspnoea—Methotrexate—esophageal cancer	0.000722	0.00105	CcSEcCtD
Oxcarbazepine—Somnolence—Methotrexate—esophageal cancer	0.00072	0.00104	CcSEcCtD
Oxcarbazepine—Dizziness—Capecitabine—esophageal cancer	0.00072	0.00104	CcSEcCtD
Oxcarbazepine—Dyspepsia—Methotrexate—esophageal cancer	0.000713	0.00103	CcSEcCtD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000709	0.00258	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000705	0.00257	CbGpPWpGaD
Oxcarbazepine—Decreased appetite—Methotrexate—esophageal cancer	0.000704	0.00102	CcSEcCtD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000702	0.00256	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.000701	0.00255	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.0007	0.00101	CcSEcCtD
Oxcarbazepine—Fatigue—Methotrexate—esophageal cancer	0.000699	0.00101	CcSEcCtD
Oxcarbazepine—Pain—Methotrexate—esophageal cancer	0.000693	0.001	CcSEcCtD
Oxcarbazepine—Vomiting—Capecitabine—esophageal cancer	0.000692	0.001	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.00069	0.00251	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CAPZA1—esophageal cancer	0.000688	0.0025	CbGpPWpGaD
Oxcarbazepine—Rash—Capecitabine—esophageal cancer	0.000686	0.000993	CcSEcCtD
Oxcarbazepine—Dermatitis—Capecitabine—esophageal cancer	0.000686	0.000992	CcSEcCtD
Oxcarbazepine—Headache—Capecitabine—esophageal cancer	0.000682	0.000987	CcSEcCtD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000673	0.00245	CbGpPWpGaD
Oxcarbazepine—Feeling abnormal—Methotrexate—esophageal cancer	0.000668	0.000966	CcSEcCtD
Oxcarbazepine—Clobazam—ABCB1—esophageal cancer	0.000667	0.0195	CrCbGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000667	0.00243	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.000666	0.00243	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.000664	0.00242	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000663	0.000959	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—ACTB—esophageal cancer	0.000662	0.00241	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.000659	0.0024	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000655	0.00239	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CTNNA1—esophageal cancer	0.00065	0.00237	CbGpPWpGaD
Oxcarbazepine—Nausea—Capecitabine—esophageal cancer	0.000647	0.000935	CcSEcCtD
Oxcarbazepine—Urticaria—Methotrexate—esophageal cancer	0.000644	0.000931	CcSEcCtD
Oxcarbazepine—Body temperature increased—Methotrexate—esophageal cancer	0.000641	0.000927	CcSEcCtD
Oxcarbazepine—Abdominal pain—Methotrexate—esophageal cancer	0.000641	0.000927	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000627	0.00228	CbGpPWpGaD
Oxcarbazepine—Carbamazepine—ABCB1—esophageal cancer	0.000626	0.0183	CrCbGaD
Oxcarbazepine—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.000624	0.00227	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—ABL1—esophageal cancer	0.000621	0.00226	CbGpPWpGaD
Oxcarbazepine—SCN5A—L1CAM interactions—EGFR—esophageal cancer	0.000618	0.00225	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000613	0.00223	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Methotrexate—esophageal cancer	0.000597	0.000864	CcSEcCtD
Oxcarbazepine—Asthenia—Methotrexate—esophageal cancer	0.000581	0.000841	CcSEcCtD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000577	0.0021	CbGpPWpGaD
Oxcarbazepine—Pruritus—Methotrexate—esophageal cancer	0.000573	0.000829	CcSEcCtD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000573	0.00209	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000566	0.00206	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000559	0.00204	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Methotrexate—esophageal cancer	0.000554	0.000802	CcSEcCtD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000547	0.00199	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.000542	0.00197	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000539	0.00196	CbGpPWpGaD
Oxcarbazepine—Dizziness—Methotrexate—esophageal cancer	0.000536	0.000775	CcSEcCtD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000532	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000531	0.00193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000527	0.00192	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000527	0.00192	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000524	0.00191	CbGpPWpGaD
Oxcarbazepine—Vomiting—Methotrexate—esophageal cancer	0.000515	0.000745	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.000515	0.00188	CbGpPWpGaD
Oxcarbazepine—Rash—Methotrexate—esophageal cancer	0.000511	0.000739	CcSEcCtD
Oxcarbazepine—Dermatitis—Methotrexate—esophageal cancer	0.00051	0.000739	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.000509	0.00185	CbGpPWpGaD
Oxcarbazepine—Headache—Methotrexate—esophageal cancer	0.000508	0.000734	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000499	0.00182	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000497	0.00181	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000492	0.00179	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000491	0.00179	CbGpPWpGaD
Oxcarbazepine—Trimipramine—ABCB1—esophageal cancer	0.000485	0.0142	CrCbGaD
Oxcarbazepine—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.000483	0.00176	CbGpPWpGaD
Oxcarbazepine—Nausea—Methotrexate—esophageal cancer	0.000481	0.000696	CcSEcCtD
Oxcarbazepine—SCN5A—Axon guidance—KDR—esophageal cancer	0.000471	0.00171	CbGpPWpGaD
Oxcarbazepine—Promethazine—ABCB1—esophageal cancer	0.000467	0.0137	CrCbGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000465	0.00169	CbGpPWpGaD
Oxcarbazepine—Doxepin—ABCB1—esophageal cancer	0.000462	0.0135	CrCbGaD
Oxcarbazepine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000462	0.00168	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MET—esophageal cancer	0.000461	0.00168	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ATP1B2—esophageal cancer	0.000456	0.00166	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ABL1—esophageal cancer	0.000443	0.00161	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000441	0.00161	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000437	0.00159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00043	0.00157	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.00043	0.00156	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—SMAD4—esophageal cancer	0.000429	0.00156	CbGpPWpGaD
Oxcarbazepine—Desipramine—ABCB1—esophageal cancer	0.000424	0.0124	CrCbGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000424	0.00154	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000419	0.00153	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—DOCK2—esophageal cancer	0.000412	0.0015	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000411	0.00149	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000405	0.00147	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.0004	0.00145	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000396	0.00144	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000394	0.00144	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000394	0.00143	CbGpPWpGaD
Oxcarbazepine—Diazepam—ABCB1—esophageal cancer	0.000389	0.0114	CrCbGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000386	0.00141	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000381	0.00139	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000374	0.00136	CbGpPWpGaD
Oxcarbazepine—Imipramine—ABCB1—esophageal cancer	0.00036	0.0105	CrCbGaD
Oxcarbazepine—Amitriptyline—ABCB1—esophageal cancer	0.000358	0.0105	CrCbGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000357	0.0013	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PFN1—esophageal cancer	0.000356	0.00129	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000352	0.00128	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000342	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000342	0.00124	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—ERBB2—esophageal cancer	0.000337	0.00123	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KDR—esophageal cancer	0.000336	0.00122	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MET—esophageal cancer	0.000329	0.0012	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000326	0.00119	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—NOTCH1—esophageal cancer	0.000316	0.00115	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00031	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000306	0.00112	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000298	0.00108	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.00029	0.00106	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CFL1—esophageal cancer	0.000288	0.00105	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CREBBP—esophageal cancer	0.000287	0.00104	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—GNG7—esophageal cancer	0.000272	0.000989	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000268	0.000977	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000268	0.000977	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000267	0.000974	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—esophageal cancer	0.000264	0.000961	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00026	0.000947	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000259	0.000943	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000247	0.000899	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000243	0.000887	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ERBB2—esophageal cancer	0.00024	0.000875	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000235	0.000856	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—EGFR—esophageal cancer	0.000233	0.00085	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000233	0.00085	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000232	0.000845	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC52A3—esophageal cancer	0.000231	0.000841	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—BLVRB—esophageal cancer	0.000231	0.000841	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000229	0.000833	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000228	0.000831	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA1—esophageal cancer	0.000228	0.000831	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HSPA5—esophageal cancer	0.000221	0.000806	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA2—esophageal cancer	0.000209	0.00076	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000207	0.000755	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000207	0.000755	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000207	0.000752	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA1—esophageal cancer	0.000196	0.000715	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC10A2—esophageal cancer	0.000196	0.000715	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EP300—esophageal cancer	0.000195	0.000712	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000194	0.000706	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000194	0.000706	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000185	0.000675	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA2—esophageal cancer	0.00018	0.000654	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA1—esophageal cancer	0.000176	0.000642	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000176	0.000642	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000176	0.000639	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.00017	0.000619	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PLCE1—esophageal cancer	0.000167	0.000608	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ADH7—esophageal cancer	0.000167	0.000608	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EGFR—esophageal cancer	0.000167	0.000606	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000165	0.000601	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ABL1—esophageal cancer	0.000164	0.000597	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000163	0.000592	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA2—esophageal cancer	0.000161	0.000587	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000158	0.000576	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000158	0.000574	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000154	0.000561	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ADH7—esophageal cancer	0.00015	0.000546	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.00015	0.000546	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000148	0.00054	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000147	0.000535	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000147	0.000535	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ADH1B—esophageal cancer	0.000146	0.000533	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000143	0.000522	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000141	0.000513	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TYMP—esophageal cancer	0.00014	0.00051	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000137	0.000501	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP26A1—esophageal cancer	0.000136	0.000496	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000136	0.000494	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000134	0.000489	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALOX15—esophageal cancer	0.000133	0.000483	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000131	0.000479	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000128	0.000466	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTO1—esophageal cancer	0.000127	0.000461	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TPI1—esophageal cancer	0.000127	0.000461	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000126	0.000458	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000125	0.000454	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000125	0.000454	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000122	0.000445	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALDOB—esophageal cancer	0.000121	0.000442	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.00012	0.000436	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000119	0.000434	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS2—esophageal cancer	0.000118	0.00043	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GAPDH—esophageal cancer	0.000117	0.000425	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CRABP1—esophageal cancer	0.000116	0.000422	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000114	0.000415	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.000114	0.000414	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TPI1—esophageal cancer	0.000114	0.000414	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000113	0.00041	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GNG7—esophageal cancer	0.00011	0.000401	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000109	0.000397	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000107	0.000389	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000107	0.000389	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CREBBP—esophageal cancer	0.000106	0.000387	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA1—esophageal cancer	0.000106	0.000386	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000106	0.000386	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000105	0.000383	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000105	0.000383	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000105	0.000382	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.000104	0.000378	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000104	0.000378	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALDH2—esophageal cancer	0.000103	0.000376	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GNG7—esophageal cancer	9.89e-05	0.00036	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—esophageal cancer	9.82e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2A6—esophageal cancer	9.7e-05	0.000353	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA2—esophageal cancer	9.7e-05	0.000353	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.66e-05	0.000352	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS3—esophageal cancer	9.5e-05	0.000346	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALDH2—esophageal cancer	9.26e-05	0.000337	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ENO1—esophageal cancer	9.2e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS1—esophageal cancer	9.2e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.19e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	9.08e-05	0.000331	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSME2—esophageal cancer	9.06e-05	0.00033	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSME1—esophageal cancer	9.06e-05	0.00033	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ADH7—esophageal cancer	9.02e-05	0.000328	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.02e-05	0.000328	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.81e-05	0.000321	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.71e-05	0.000317	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.68e-05	0.000316	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	8.54e-05	0.000311	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ENO1—esophageal cancer	8.26e-05	0.000301	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS1—esophageal cancer	8.26e-05	0.000301	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSME1—esophageal cancer	8.14e-05	0.000296	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSME2—esophageal cancer	8.14e-05	0.000296	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.91e-05	0.000288	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.91e-05	0.000288	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1B1—esophageal cancer	7.82e-05	0.000285	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.79e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TYMP—esophageal cancer	7.56e-05	0.000275	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCB1—esophageal cancer	7.48e-05	0.000272	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP19A1—esophageal cancer	7.35e-05	0.000268	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.35e-05	0.000268	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EP300—esophageal cancer	7.23e-05	0.000263	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.16e-05	0.000261	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.1e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	7.02e-05	0.000256	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TPI1—esophageal cancer	6.83e-05	0.000249	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.83e-05	0.000249	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMOX1—esophageal cancer	6.71e-05	0.000244	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.6e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.58e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.55e-05	0.000239	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCB1—esophageal cancer	6.44e-05	0.000234	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.31e-05	0.00023	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.25e-05	0.000228	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMOX1—esophageal cancer	6.02e-05	0.000219	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GNG7—esophageal cancer	5.94e-05	0.000216	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.91e-05	0.000215	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.78e-05	0.000211	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.57e-05	0.000203	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—esophageal cancer	5.35e-05	0.000195	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.3e-05	0.000193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.24e-05	0.000191	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—esophageal cancer	5.17e-05	0.000188	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CREBBP—esophageal cancer	5e-05	0.000182	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.96e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.96e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.89e-05	0.000178	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.89e-05	0.000178	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.87e-05	0.000177	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NOS3—esophageal cancer	4.47e-05	0.000163	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.37e-05	0.000159	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CREBBP—esophageal cancer	4.3e-05	0.000157	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.22e-05	0.000154	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—esophageal cancer	4.09e-05	0.000149	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.97e-05	0.000145	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.86e-05	0.000141	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NOS3—esophageal cancer	3.85e-05	0.00014	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.62e-05	0.000132	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—esophageal cancer	3.52e-05	0.000128	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.48e-05	0.000127	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NOS3—esophageal cancer	3.46e-05	0.000126	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—EP300—esophageal cancer	3.4e-05	0.000124	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.16e-05	0.000115	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—EP300—esophageal cancer	2.93e-05	0.000107	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—EP300—esophageal cancer	2.63e-05	9.58e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.52e-05	9.17e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.32e-05	8.46e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—esophageal cancer	2.17e-05	7.9e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NOS3—esophageal cancer	2.08e-05	7.57e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.95e-05	7.09e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.9e-05	6.93e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—EP300—esophageal cancer	1.58e-05	5.76e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.17e-05	4.26e-05	CbGpPWpGaD
